ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
JPMorgan Chase & Co

JPMorgan Chase & Co (1JPM)

203.45
-1.80
(-0.88%)
Closed April 21 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

1JPM News

Official News Only
0 articles were found

1JPM Financials

Financials

Discussion

View Full Feed
misterfishman misterfishman 4 minutes ago
Hey,watch your mouth don't talk to my big bro like that.keep it up and you will see what happens.
IGPK
ksquared ksquared 6 minutes ago
You've lived a wonderful life.
Keep it up. You're still in the swing of things.
Zardiw Zardiw 8 minutes ago
Palms Haven Recovery

https://PalmsHaven.com
https://PalmsHaven.com/Pictures/Palms5.jpg

Z
sab63090 sab63090 9 minutes ago
Reduce the deficit which is a big factor in reducing inflation; it's not destruction, it's prudent....

I'm not smart enough to debate tariffs, but I certainly recognize when something stinks. China has been abusing "the ongoing system" for many decades using child labor with American
AVXL
uranium-pinto-beans uranium-pinto-beans 9 minutes ago
VRNA
Cantor starts Verona at Overweight, says momentum 'just getting started'
Cantor Fitzgerald initiated coverage of Verona Pharma with an Overweight rating and $80 price target. The firm considers Verona one of the best stories in biotech. The firm believes Ohtuvayre's launch in c
VRNA
uranium-pinto-beans uranium-pinto-beans 9 minutes ago
VRNA
Cantor starts Verona at Overweight, says momentum 'just getting started'
Cantor Fitzgerald initiated coverage of Verona Pharma with an Overweight rating and $80 price target. The firm considers Verona one of the best stories in biotech. The firm believes Ohtuvayre's launch in c
VRNA
uranium-pinto-beans uranium-pinto-beans 10 minutes ago
MSFT
Microsoft price target lowered to $430 from $475 at Barclays
Barclays lowered the firm's price target on Microsoft to $430 from $475 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for U.S. software. The firm says Q1 "will unlikely be a major catal
MSFT
uranium-pinto-beans uranium-pinto-beans 10 minutes ago
NOW
ServiceNow price target lowered to $967 from $1,200 at Barclays
Barclays analyst Raimo Lenschow lowered the firm's price target on ServiceNow to $967 from $1,200 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for U.S. software. The firm says Q1 "wi
halbroke1 halbroke1 10 minutes ago
HMBL $$$ COULD SEE A MOON SHOT SOON, IT WILL BRING BACK THE MEMORIES FROM THE TS*NP DAYS..
HMBL
sylvia07 sylvia07 10 minutes ago
Buy or hold....
https://stockinvest.us/stock/DBMM
DBMM
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
NFLX
Netflix price target raised to $1,200 from $1,150 at Morgan Stanley
Morgan Stanley raised the firm's price target on Netflix to $1,200 from $1,150 and keeps an Overweight rating on the shares. Netflix is "a predictable business" and that predictability, combined with a business
NFLX
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
AMZN, META, UBER, MELI
Raymond James downgrades Amazon to Outperform on earnings pressures
Raymond James analyst Josh Beck downgraded Amazon.com (AMZN) to Outperform from Strong Buy with a price target of $195, down from $275. Due to an "uneven" macro environment, tariffs, and "stee
AMZN UBER
halbroke1 halbroke1 13 minutes ago
GCAN $$$$ COULD BE A VERY EXPLOSIVE DAY TODAY AND THIS WEEK, I CANT WAIT TO SEE THE MOON $$$ SOON.
GCAN
Truthsocial Truthsocial 15 minutes ago
WATCH WALLSTREET BLOODBATH

Let's go RDGL
RDGL
op1 op1 15 minutes ago
No doubt kidron was and has been working on deals just seems to not
be able to close
Oh well nothing ventured nothing gained
Still hopeful
WDDD
EternalPatience EternalPatience 17 minutes ago
We have to look at what Pulye has done so far objectively based on facts alone taking away our political leaning hat away..
Has there been any solid evidence that is out there from him (,,X post or interviews) where he said anything. About exit?  NO. 
Does he have the intention to?  Pr
FNMA
Hoskuld Hoskuld 17 minutes ago
Hi Kentucky. Regarding partnership, I still think partnership has to wait for more evidence that risk is fully wrung out. BP wants to know they have a drug they can definitely put into their machine and scale out in a big enough way that it provides the sustenance the BP needs to survive. They wo
AVXL
newmedman newmedman 18 minutes ago
Larry the cat has thoughts...

https://bsky.app/profile/number10cat.bsky.social/post/3lncq4vcaqc2jLarr

https://bsky.app/profile/number10cat.bsky.social/post/3lncq4vcaqc2j
TheKid5 TheKid5 21 minutes ago
Reactor shipping on 4/28. 3 days in transit and then installation. Oil should start flowing in 3rd quarter , which is a couple months ahead of time. YUGE funding news in the next few weeks. 6 or 7 projects to announce after funding. Exciting times at CLNV
CLNV
sab63090 sab63090 22 minutes ago
boi568

You don't think that Dr. Jin knows exactly what the FDA wants?

Too many reasons to apply that we know about and endorsed by experts....something is slowing things down and it's probably Missling's motivations in discussions with unannounced interested parties..
AVXL
weedtrader420 weedtrader420 24 minutes ago
BITCOIN said, what a great day. The king of child molesters is dead $100k target ✊😎
BTCUSD
Seminole Red Seminole Red 27 minutes ago
A week off, great, I have a few players that could use some practice